HomeLUPIN • NSE
add
Lupin Ltd
Previous close
₹2,092.00
Day range
₹2,083.10 - ₹2,105.00
Year range
₹1,795.20 - ₹2,402.90
Market cap
957.64B INR
Avg Volume
1.18M
P/E ratio
33.63
Dividend yield
0.57%
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 70.48B | 24.23% |
Operating expense | 34.02B | 18.41% |
Net income | 14.78B | 73.34% |
Net profit margin | 20.97 | 39.52% |
Earnings per share | 32.28 | 73.18% |
EBITDA | 21.29B | 56.27% |
Effective tax rate | 26.02% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.82B | 115.71% |
Total assets | 335.00B | 31.47% |
Total liabilities | 137.72B | 41.07% |
Total equity | 197.28B | — |
Shares outstanding | 456.71M | — |
Price to book | 4.87 | — |
Return on assets | — | — |
Return on capital | 18.70% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 14.78B | 73.34% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Founded
1968
Headquarters
Website
Employees
24,006
